• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Defibrillator implantation without induction of ventricular fibrillation: good enough?

作者信息

Curtis Anne B

出版信息

Circulation. 2007 May 8;115(18):2370-2. doi: 10.1161/CIRCULATIONAHA.107.698548.

DOI:10.1161/CIRCULATIONAHA.107.698548
PMID:17485589
Abstract
摘要

相似文献

1
Defibrillator implantation without induction of ventricular fibrillation: good enough?不诱发心室颤动进行除颤器植入：这样就足够了吗？
Circulation. 2007 May 8;115(18):2370-2. doi: 10.1161/CIRCULATIONAHA.107.698548.
2
Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).大多数植入式心脏复律除颤器/心脏再同步治疗除颤器患者可行无诱导或有限电击测试：多中心ASSURE研究（心律失常单次电击除颤阈值测试与易损性上限：植入式心脏复律除颤器植入的风险降低评估）结果
Circulation. 2007 May 8;115(18):2382-9. doi: 10.1161/CIRCULATIONAHA.106.663112. Epub 2007 Apr 30.
3
Death without prior appropriate implantable cardioverter-defibrillator therapy: a competing risk study.未接受过适当植入式心脏复律除颤器治疗的死亡：一项竞争风险研究。
Circulation. 2008 Apr 15;117(15):1918-26. doi: 10.1161/CIRCULATIONAHA.107.742155. Epub 2008 Apr 7.
4
Is defibrillation testing necessary for implantable transvenous defibrillators?: defibrillation testing is necessary at the time of implantable cardioverter defibrillator implantation.植入式经静脉除颤器是否需要进行除颤测试？：在植入式心脏复律除颤器植入时需要进行除颤测试。
Circ Arrhythm Electrophysiol. 2014 Apr;7(2):337-46. doi: 10.1161/CIRCEP.113.000371.
5
The implantable cardiac defibrillator.植入式心脏除颤器。
Br J Hosp Med. 1996;55(1-2):37-41.
6
Induction of ventricular fibrillation rather than ventricular tachycardia predicts tachyarrhythmia recurrences in patients with idiopathic dilated cardiomyopathy and implantable cardioverter defibrillator for secondary prophylaxis.在患有特发性扩张型心肌病且植入式心脏复律除颤器用于二级预防的患者中，诱发心室颤动而非室性心动过速可预测快速性心律失常复发。
Europace. 2009 Mar;11(3):289-96. doi: 10.1093/europace/eun330. Epub 2008 Dec 18.
7
Wide QRS, narrow QRS: what's the difference?宽QRS波、窄QRS波：有何区别？
J Am Coll Cardiol. 2005 Jul 19;46(2):317-9. doi: 10.1016/j.jacc.2005.04.021.
8
Present guidelines for device implantation: clinical considerations and clinical challenges from pacing, implantable cardiac defibrillator, and cardiac resynchronization therapy.当前设备植入指南：起搏、植入式心脏除颤器及心脏再同步治疗的临床考量与临床挑战
Circulation. 2014 Jan 21;129(3):383-94. doi: 10.1161/CIRCULATIONAHA.112.000762.
9
Defibrillation threshold testing and neurologic outcome.除颤阈值测试与神经学结果。
Anadolu Kardiyol Derg. 2007 Jul;7 Suppl 1:47-9.
10
Increased N-terminal-pro-B-type natriuretic peptide levels in patients with appropriate implantable defibrillator therapies.接受适当植入式心脏除颤器治疗的患者中N末端B型利钠肽原水平升高。
Heart Lung. 2009 Jan-Feb;38(1):10-6. doi: 10.1016/j.hrtlng.2007.12.005. Epub 2008 Sep 11.

引用本文的文献

1
Defibrillation threshold testing fails to show clinical benefit during long-term follow-up of patients undergoing cardiac resynchronization therapy defibrillator implantation.心脏再同步治疗除颤器植入患者长期随访中，除颤阈值测试未能显示临床获益。
Europace. 2011 May;13(5):683-8. doi: 10.1093/europace/euq519. Epub 2011 Jan 19.